Skip to main content
. 2020 Jun 30;13(2 Suppl):947S–955S. doi: 10.1177/1947603520934858

Figure 2.

Figure 2.

Cell viability of osteoarthritis (OA) patient chondrocytes after treatment with different concentrations of interleukin-1β (IL-1β) for 24 hours (A), n = 6. (B) ELISA was used to measure the HMGB1 levels in chondrocytes stimulated with IL-1β (10 ng/mL) over the time course, n = 6 for each time point. (C) Viability of chondrocytes after treatment with glycyrrhizin at indicated concentrations for 24 hours, n = 6. (D) Viability of chondrocytes after co-treatment of IL-1β (10 ng/mL) and glycyrrhizin at indicated concentrations for 24 hours (n = 6). All the experiments were repeated independently 3 times. #P < 0.05, ##P < 0.01 compared with IL-1β treatment. *P < 0.05, **P < 0.01, ***P < 0.001 compared with NC.